OUTLOOK THERAPEUTICS, INC. (OTLK) Debt / Equity
- 2020-06-30: Debt/Equity Ratio 88.19.
- 2019-09-30: Debt/Equity Ratio -66.74.
- 2019-06-30: Debt/Equity Ratio -0.17.
- 2019-03-31: Debt/Equity Ratio -0.04.
Complete source-backed debt/equity ratio history.
- Available history
- 2016-09-30 to 2020-06-30
- Data captured
Historical Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|---|
| 2020-06-30 | 88.19 |
| 2019-09-30 | -66.74 |
| 2019-06-30 | -0.17 |
| 2019-03-31 | -0.04 |
| 2018-12-31 | -0.01 |
| 2018-09-30 | -0.01 |
| 2018-06-30 | -0.02 |
| 2018-03-31 | -0.01 |
| 2017-12-31 | -0.01 |
| 2017-09-30 | -0.01 |
| 2016-09-30 | -0.55 |
Annual Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|---|
| 2019-09-30 | -0.07 |
| 2018-09-30 | -0.01 |
| 2017-09-30 | -0.01 |
| 2016-09-30 | -0.55 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |